Genesystem Co., Ltd. (KOSDAQ:363250)
South Korea · Delayed Price · Currency is KRW 3,230.00
-75.00 (-2.27%)
At close: Jul 10, 2026
Genesystem Market Cap
Genesystem has a market cap or net worth of 26.76 billion as of July 10, 2026. Its market cap has decreased by -57.90% in one year.
Market Cap
26.76B
Enterprise Value
25.48B
Revenue
647.07M
Ranking
n/a
PE Ratio
n/a
Stock Price
3,230.00
Market Cap Chart
Since May 26, 2021, Genesystem's market cap has decreased from 118.51B to 26.76B, a decrease of -77.42%. That is a compound annual growth rate of -25.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 26.76B | -4.29% |
| Dec 30, 2025 | 27.96B | -52.89% |
| Dec 30, 2024 | 59.36B | -8.92% |
| Dec 28, 2023 | 65.17B | 12.35% |
| Dec 29, 2022 | 58.00B | -26.36% |
| Dec 30, 2021 | 78.77B | -33.54% |
| May 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DRGEM | 54.70B |
| QuantaMatrix | 45.91B |
| Genoray | 43.16B |
| JPI Healthcare | 36.81B |
| Noul Co.,Ltd. | 34.01B |
| UXN Co., Ltd. | 33.09B |
| MEKICS CO., | 28.67B |
| BTB Korea Co.,Ltd | 26.42B |